Potential benefits of biologics on stroke and mortality in patients with rheumatoid arthritis: A nationwide population-based cohort study in Taiwan.

Tang, Chao-Hsiun; Yu, Fun; Huang, Ching-Ya; Chen, Der-Yuan

Tang, Chao-Hsiun; Yu, Fun; Huang, Ching-Ya; Chen, Der-Yuan.

Affiliation

Tang CH; School of Health Care Administration, Taipei Medical University, Taipei, Taiwan.
Yu F; Pfizer Ltd., New Taipei City, Taiwan.
Huang CY; Formosa Biomedical Technology Corporation, Taipei, Taiwan.
Chen DY; Rheumatology and Immunology Center, China Medical University Hospital, Taichung, Taiwan.

Int J Rheum Dis ; 22(8): 1544-1552, 2019 Aug.

Article in En | MEDLINE | ID: mdl-31240863

Subject(s)

Antirheumatic Agents/therapeutic use; Arthritis, Rheumatoid/drug therapy; Biological Products/therapeutic use; Stroke/prevention & control; Adult; Antirheumatic Agents/adverse effects; Arthritis, Rheumatoid/diagnosis; Arthritis, Rheumatoid/mortality; Biological Products/adverse effects; Cause of Death; Cross-Sectional Studies; Databases, Factual; Female; Humans; Longitudinal Studies; Male; Middle Aged; Protective Factors; Retrospective Studies; Risk Assessment; Risk Factors; Stroke/diagnosis; Stroke/mortality; Taiwan/epidemiology; Time Factors; Treatment Outcome

Key words

biological therapies; clinical outcomes; disease-modifying antirheumatic drugs; rheumatoid arthritis; stroke

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Biological Products / Antirheumatic Agents / Stroke Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Rheum Dis Journal subject: REUMATOLOGIA Year: 2019 Type: Article Affiliation country: Taiwan

Fulltext

XML

PubMed Links

Search on Google